Q1LS94 AF NFT

Arginine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeieip5gb5r2ftw4ixvu2acgwzsknsu7pordv67c3kxazt2kdeskuvq/metadata.json
IPFS of structure file: 
bafybeiccg2nhuxqjfedy7fiwkqrfxedwpbbxqkmta2cz4gmiij55yramfa/AF-Q1LS94-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xd302f04514ad817d3281793c7434A949dEEd5b52
First NFT owner address (bech32): 
genesis16vp0q3g54kqh6v5p0y78gd9ff80w6k6jydc3f9
Current NFT ID #452644 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
452644
Accession (UniProt):
Q1LS94
Name::
Arginine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
CUPRIAVIDUS METALLIDURANS (STRAIN ATCC 43123 / DSM 2839 / NBRC 102507 / CH34)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q1LS94 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q1LS94|SYR_CUPMC Arginine--tRNA ligase OS=Cupriavidus metallidurans (strain ATCC 43123 / DSM 2839 / NBRC 102507 / CH34) OX=266264 GN=argS PE=3 SV=1 MLPVQTSQLAAAFTDAVRALAPADANLPAVTFERPKAAAHGDLACNIAMQVAKSLKTNPRELAQKVVDAVKADSRATALVAALEIAGPGFINLRLSPEARAEVLRAVLADGDRYGARPVGEHGQVLVEFVSANPTGPLHVGHGRQAALGDALANLLAWQGWSVHREFYYNDAGVQIHTLAISVQARARGLKPGDAGWPESAYNGDYIADIAADFLAGKTVSASDGEPVTASGNIEDLESIRKFAVTYLRNEQDIDLQAFGVKFDRYYLESSLYSDGRVEAAVQSLIAKGKTYESEGALWLRTTDDGDDKDRVMKKGDGTYTYFVPDVAYHTTKWERGFSKVINVQGSDHHGTIARVRAGLQGLDIGIPQGYPDYVLHKMVTVMKNGEEVKISKRAGSYVTVRDLIEWSNGGEETIRGCLEAGVADWPAHFTRGRDAVRFFLLSRKADTEFVFDVDLALKQNDENPVYYVQYAHARICSIFEAWGGADWEARLGELASVDLAAVTAADVSPQAIALGRRLAEFPDMLAAASSELAPHAVAFYLRDLAGDFHAFYNADRVLVDDETVKRARLALLAATRQVLKNGLAVIGVSAPQRMDREAAPA